## Core Concept
G6PD (Glucose-6-phosphate dehydrogenase) deficiency is a genetic disorder that affects the enzyme G6PD, which helps protect red blood cells from damage caused by oxidation. This condition primarily affects red blood cells, making them more susceptible to hemolysis (rupture) under certain conditions, such as exposure to specific drugs, infections, or certain foods.

## Why the Correct Answer is Right
The correct answer, , is a class of drugs that are not typically associated with inducing hemolysis in G6PD deficiency. Drugs that cause hemolysis in G6PD deficiency typically work by generating reactive oxygen species (ROS) or by directly oxidizing the G6PD-deficient red blood cells.

## Why Each Wrong Option is Incorrect
* **Option A:** - Certain antimalarial drugs, such as primaquine, can induce hemolysis in individuals with G6PD deficiency. These drugs generate oxidative stress, which G6PD-deficient red blood cells cannot handle.
* **Option B:** - Some antibiotics, like sulfonamides and trimethoprim-sulfamethoxazole, can cause hemolysis in G6PD-deficient individuals for the same reason; they increase oxidative stress.
* **Option D:** - NSAIDs (Nonsteroidal anti-inflammatory drugs) can also precipitate hemolysis in G6PD deficiency, although the risk may vary with the specific drug.

## Clinical Pearl / High-Yield Fact
A key point to remember is that not all drugs within a particular class will induce hemolysis in G6PD deficiency, but certain classes are more commonly associated with this risk. For example, the antibiotic "sulfa" drugs are well-known to potentially cause hemolysis.

## Correct Answer: .